Misdiagnosis of bipolar disorder as borderline personality disorder: clinical and economic consequences

References

• Akiskal H, Judd LL, Lemmi H. Subthreshold depressions: clinical and polysomnographic validation of dysthymic, residual and masked forms. J Affect Disord 1997; 45: 53–63
   PubMed Web of Science ®Google Scholar
• Balazs J, Benazzi F, Rihmer Z, et al. The close link between suicide attempts and mixed (bipolar) depression: implications for suicide prevention. J Affective Disord 2006; 91: 133–138
   PubMed Web of Science ®Google Scholar
• Benazzi F. Borderline personality-bipolar spectrum relationship. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30: 68–74
   PubMed Web of Science ®Google Scholar
• Benazzi F, Koukopoulos A, Akiskal HS. Toward a validation of a new definition of agitated depression as a bipolar mixed state (mixed depression). Eur Psychiatry 2004; 19: 85–90
   PubMed Web of Science ®Google Scholar
• Binks CA, Fenton M, McCarthy L, Lee T, Adams CE, Duggan C. Pharmacological interventions for people with borderline personality disorder. Cochrane Database Syst Rev 2006; 1: CD005653
   Google Scholar
• Bogenschutz MP, Nurnberg GH. Olanzapine versus placebo in the treatment of borderline personality disorder. J Clin Psychiatry 2004; 65: 104–109
   PubMed Web of Science ®Google Scholar
• Evins AE. Efficacy of newer anticonvusant medications in bipolar spectrum mood disorders. J Clin Psychiatry 2003; 64: 9–14
   PubMed Web of Science ®Google Scholar
• First, MB, Spitzer, RL, Gibbon, M, Williams, JBW. 1994. Structured Clinical Interview for Axis I DSM-IV Disorders, patient edition. SCID-I/P, Version 2.0. New York: New York State Psychiatric Institute, Biometrics Research.
   Google Scholar
• First, MB, Spitzer, RL, Gibbon, M, Williams, JBW, Benjamin, L. 1997. Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II). Biometrics Research Department, New York State Psychiatric Institute, Biometrics Research
   Google Scholar
• Frankenburg FR, Zanarini MC. Divalprox sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo controlled pilot study. J Clin Psychiatry 2002; 63: 442–446
   PubMed Web of Science ®Google Scholar
• Ghaemi SN, Ko JY, Goodwin FK. “Cade's disease” and beyond: misdiagnosis, antidepressant use, and a proposed definition for bipolar spectrum disorder. Can J Psychiatry 2002; 47: 125–134
   PubMed Web of Science ®Google Scholar
• Gunderson JG, Weinberg I, Daversa MT, et al. Descriptive and longitudinal observations on the relationship of borderline personality disorder and bipolar disorder. Am J Psychiatry 2006; 163: 1173–1178
   PubMed Web of Science ®Google Scholar
• Hadjipavlou G, Mok H, Yatham LN. Pharmcotherpay of bipolar II disorder: a critical review of current evidence. Bipolar Disord 2004; 6: 14–25
   PubMed Web of Science ®Google Scholar
• Hilger E, Barnas C, Kasper S. Quetiapine in the treatment of borderline personality disorder. World J Biol Psychiatry 2003; 1: 42–44
   Google Scholar
• Hollander E, Allen A, Lopez RP, et al. A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder. J Clin Psychiatry 2001; 62: 199–203
   PubMed Web of Science ®Google Scholar
• Hollander E, Swann A, Coccaro EF, Jiang P, Smith TB. Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder. Am J Psychiatry 2005; 162: 621–624
   PubMed Web of Science ®Google Scholar
• Krawitz R. Borderline Personality Disorder: Attitudinal change following training. Aust NZ J Psychiatry 2004; 38: 554–559
   PubMed Web of Science ®Google Scholar
• Lewis G, Appleby L. Personality disorder: the patients psychiatrists dislike. Br J Psychiatry 1988; 153: 44–49
   PubMed Web of Science ®Google Scholar
• Magill C. The boundry between borderline personality disorder and bipolar disorder: current concepts and challenges. Can J Psychiatry 2004; 49: 551–556
   PubMed Web of Science ®Google Scholar
• Moller HJ, Nasrallah HA. Treatment of bipolar disorder. J Clin Psychiatry 2003; 64: 9–17
   PubMed Web of Science ®Google Scholar
• Paris J, Gunderson J, Weinberg I. The interface between borderline personality disorder and bipolar spectrum disorders. Compr Psychiatry 2007; 48: 145–154
   PubMed Web of Science ®Google Scholar
• Perlis RH, Welge JA, Vornik LA, Hirschfeld RM, Keck PE. Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials. J Clin Psychiatry 2006; 67: 509–516
   PubMed Web of Science ®Google Scholar
• Pfohl, B, Silk, K, Robins, C.. Attitudes towards borderline personality disorder: a survey of 752 clinicians. Geneva: International Society for the Study of Personality Disorders 6th International Congress on the Disorders of Personality. 1999
   Google Scholar
• Pinto OC, Akiskal HS. Lamotrigine as a promising approach to borderline personality: an open case series without concurrent DSM-IV major mood disorder. J Affect Disord 1998; 51: 333–343
   PubMed Web of Science ®Google Scholar
• Preston GA, Marchant BK, Reimherr FW, Strong RE, Hedges W. Borderline personality disorder in patients with bipolar disorder and response to lamotrigine. J Affect Disord 2004; 79: 97–303
   PubMed Web of Science ®Google Scholar
• Sharma V. Loss of response to antidepressants and subsequent refractoriness: diagnostic and treatment issues. J Affect Disord 2001; 64: 99–106
   PubMed Web of Science ®Google Scholar
• Sharma V, Khan M, Smith A. A closer look at treatment resistant depression: is it due to a bipolar diathesis?. J Affect Disord 2005; 84: 251–257
   PubMed Web of Science ®Google Scholar
• Skokol A, Gunderson JG, Pfohl B, et al. The borderline diagnosis I: psychopathology, comorbidity, and personality structure. Biol Psychiatry 2002; 51: 936–950
   PubMed Web of Science ®Google Scholar
• Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W. Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res 1997; 73: 159–171
   PubMed Web of Science ®Google Scholar
• Torgersen S, Kringlen E, Cramer V. The prevalence of personality disorders in a community sample. Arch Gen Psychiatry 2001; 50: 991–999
   Google Scholar
• Weilburg JP, O'Leary KM, Meigs JB, Hennen J, Stafford RS. Evaluation of the adequacy of outpatient antidepressant treatment. Psychiatr Serv 2003; 54: 1233–1239
   PubMed Web of Science ®Google Scholar
• Zanarini MC, Frankenburg FR. Olanzapine treatment of female borderline personality disorder patients: a double-blind, placebo-controlled pilot study. J Clin Psychiatry 2001; 62: 849–854
   PubMed Web of Science ®Google Scholar
• Zanarini MC, Frankenburg FR, Parachini EA. A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder. J Clin Psychiatry 2004; 65: 903–907
   PubMed Web of Science ®Google Scholar